首页 > 最新文献

Journal of Pharmacy and Nutrition Sciences最新文献

英文 中文
Current Trends in the Treatment of Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer 人表皮生长因子受体-2阴性乳腺癌的治疗现状
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-07-25 DOI: 10.29169/1927-5951.2020.10.04.5
P. Sivanandy
Breast cancer affect almost 1 in 8 women and it is highest in developed and developing countries. There are many drugs exist for the treatment of breast cancer, but still the incidence of mortality and morbidity are high among all cancer types in most countries. Even though the conventional therapies play a major role in the management of breast cancer, its complications are obvious and unavoidable. The newer targeted drug therapy came in place to reduce complications in some extent, but not fully. Hence, a review was aimed to analyse the efficacy and safety of newer anticancer drugs that approved for the treatment of breast cancer by US-FDA from 2017 to 2019. The Olaparib, Talazoparib, and Ribociclib are the newly approved drugs for the treatment of breast cancer during this review period. Among these new drugs, Olaparib and Talazoparib alone or in combination with other anticancer drugs considered as safe and efficacious. Patients with Olaparib or Talazoparib as monotherapy have median progression-free survival of 2.8 to 8.6 months longer and has 42-46% lower risk of death (P<0.001). A combination of conventional therapies and nonpharmacological approach are warranted for the best benefit of cancer patients and to improve their quality of life.
每8名女性中就有1名患有乳腺癌,在发达国家和发展中国家发病率最高。目前有许多治疗乳腺癌的药物,但在大多数国家,所有癌症类型的死亡率和发病率仍然很高。尽管传统的治疗方法在乳腺癌的治疗中起着重要的作用,但其并发症是明显的和不可避免的。新的靶向药物治疗在一定程度上减少了并发症,但不是完全减少。因此,该综述旨在分析2017年至2019年美国fda批准用于治疗乳腺癌的新型抗癌药物的有效性和安全性。奥拉帕尼(Olaparib)、塔拉唑帕尼(Talazoparib)和利博西尼(Ribociclib)是本审查期间新批准的治疗乳腺癌的药物。在这些新药中,奥拉帕尼和塔拉唑帕尼单独使用或与其他抗癌药物联合使用被认为是安全有效的。单药治疗奥拉帕尼或Talazoparib患者的中位无进展生存期延长2.8至8.6个月,死亡风险降低42-46% (P<0.001)。常规治疗和非药物治疗相结合是保证癌症患者最大利益和提高他们的生活质量。
{"title":"Current Trends in the Treatment of Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer","authors":"P. Sivanandy","doi":"10.29169/1927-5951.2020.10.04.5","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.04.5","url":null,"abstract":"Breast cancer affect almost 1 in 8 women and it is highest in developed and developing countries. There are many drugs exist for the treatment of breast cancer, but still the incidence of mortality and morbidity are high among all cancer types in most countries. Even though the conventional therapies play a major role in the management of breast cancer, its complications are obvious and unavoidable. The newer targeted drug therapy came in place to reduce complications in some extent, but not fully. Hence, a review was aimed to analyse the efficacy and safety of newer anticancer drugs that approved for the treatment of breast cancer by US-FDA from 2017 to 2019. The Olaparib, Talazoparib, and Ribociclib are the newly approved drugs for the treatment of breast cancer during this review period. Among these new drugs, Olaparib and Talazoparib alone or in combination with other anticancer drugs considered as safe and efficacious. Patients with Olaparib or Talazoparib as monotherapy have median progression-free survival of 2.8 to 8.6 months longer and has 42-46% lower risk of death (P<0.001). A combination of conventional therapies and nonpharmacological approach are warranted for the best benefit of cancer patients and to improve their quality of life.","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82829833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Parenteral Nutrition-Associated Factors on the Growth of Premature Infants 肠外营养相关因素对早产儿生长发育的影响
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-07-25 DOI: 10.29169/1927-5951.2020.10.04.2
K. Tongiew
{"title":"Effect of Parenteral Nutrition-Associated Factors on the Growth of Premature Infants","authors":"K. Tongiew","doi":"10.29169/1927-5951.2020.10.04.2","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.04.2","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"37 1","pages":"133-139"},"PeriodicalIF":0.0,"publicationDate":"2020-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81407263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Vitro Dissolution Interference Study in Presence of Paracetamol Tablets with Freshly Prepared Mango Juices on Simulated Gastrointestinal Digestion 新鲜芒果汁对扑热息痛片体外模拟胃肠消化溶出干扰研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-07-25 DOI: 10.29169/1927-5951.2020.10.04.4
Md. Didaruzzaman Sohel
{"title":"In Vitro Dissolution Interference Study in Presence of Paracetamol Tablets with Freshly Prepared Mango Juices on Simulated Gastrointestinal Digestion","authors":"Md. Didaruzzaman Sohel","doi":"10.29169/1927-5951.2020.10.04.4","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.04.4","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"31 1","pages":"148-154"},"PeriodicalIF":0.0,"publicationDate":"2020-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82804486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Medicinal Uses, Phytochemistry and Biological Activities of Markhamia tomentosa 毛毛Markhamia tomentosa的药用、植物化学和生物活性研究进展
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-07-25 DOI: 10.29169/1927-5951.2020.10.04.3
A. Maroyi
{"title":"A Review of Medicinal Uses, Phytochemistry and Biological Activities of Markhamia tomentosa","authors":"A. Maroyi","doi":"10.29169/1927-5951.2020.10.04.3","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.04.3","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"55 1","pages":"140-147"},"PeriodicalIF":0.0,"publicationDate":"2020-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74925090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Detecting Biogenic Amines in Food and Drug Plants with HPLC: Medical and Nutritional Implications 高效液相色谱法检测食品和药用植物中的生物胺:医学和营养意义
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-05-12 DOI: 10.29169/1927-5951.2020.10.03.2
A. Oleskin
{"title":"Detecting Biogenic Amines in Food and Drug Plants with HPLC: Medical and Nutritional Implications","authors":"A. Oleskin","doi":"10.29169/1927-5951.2020.10.03.2","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.03.2","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"231 2 1","pages":"88-91"},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72778828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Impact of Dietary Patterns and Nutritional Status on the Academic Performance of Omani School Students 膳食模式和营养状况对阿曼学生学业成绩的影响
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-05-12 DOI: 10.29169/1927-5951.2020.10.03.1
Amanat Ali
{"title":"Impact of Dietary Patterns and Nutritional Status on the Academic Performance of Omani School Students","authors":"Amanat Ali","doi":"10.29169/1927-5951.2020.10.03.1","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.03.1","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"24 1","pages":"74-87"},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78580220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Estimation of Efficiency of Use of Dairy Products Enriched with Enter Sorbent Dietary Fibers on Immunophysiological Indicators of the Rat Organism 富含膳食纤维的乳制品对大鼠机体免疫生理指标的影响
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-05-12 DOI: 10.29169/1927-5951.2020.10.03.3
N. Ablaikhanova
{"title":"Estimation of Efficiency of Use of Dairy Products Enriched with Enter Sorbent Dietary Fibers on Immunophysiological Indicators of the Rat Organism","authors":"N. Ablaikhanova","doi":"10.29169/1927-5951.2020.10.03.3","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.03.3","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"40 1-2 1","pages":"92-100"},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78198772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parkia biglobosa (Mimosaceae): Botany, Uses, Phytochemical Properties and Pharmacological Potential 含羞草科:植物学、用途、植物化学性质和药理潜力
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-05-12 DOI: 10.29169/1927-5951.2020.10.03.4
Collen Musara
{"title":"Parkia biglobosa (Mimosaceae): Botany, Uses, Phytochemical Properties and Pharmacological Potential","authors":"Collen Musara","doi":"10.29169/1927-5951.2020.10.03.4","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.03.4","url":null,"abstract":"","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87316014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Issues of Type 2 Diabetes Disease Effective Treatment in Kazakhstan 2型糖尿病在哈萨克斯坦的有效治疗问题
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-05-12 DOI: 10.29169/1927-5951.2020.10.03.5
N. Ablaikhanova
In his address to the people, the First President of our country, emphasized the need to introduce innovative methods of treating socially significant diseases. Among these diseases, diabetes holds a special position. More than 14,000 new cases of diabetes mellitus are officially detected annually in Kazakhstan. The real picture of the disease is difficult to compare with these data. This review discusses the prevalence of type 2 diabetes among the population of the Republic of Kazakhstan, and the causing factors such as age, race, genetic predisposition (OR = 3), obesity, glucose level and total cholesterol etc. It was found that the main complications and concomitant diseases of diabetes in residents of different regions are polyneuropathy 22.4%, diabetic retinopathy 14%, diabetic foot syndrome 13.6%, arterial hypertension 13.6% and coronary heart disease (CHD) 14.4%. Only 1.8% of the population is diagnosed with type 2 diabetes, latent manifestations of type 2 diabetes mellitus, one in four people in Kazakhstan can be sick, 38% of adults aged 20-79 suffer from prediabetes, and 8.2% with diabetes. It is believed that by 2030 in Kazakhstan, there may be about a million patients with diabetes. Diabetes mellitus, in accordance with the Code of the Republic of Kazakhstan “On the health of the people and the health care system” belongs to the category of socially significant diseases. Therefore, the study of type 2 diabetes is one of the urgent problems of the public health in Kazakhstan.
我国首任总统在对人民的讲话中强调,必须采用治疗具有社会意义的疾病的创新方法。在这些疾病中,糖尿病占有特殊的地位。哈萨克斯坦每年正式发现14 000多例新的糖尿病病例。这种疾病的真实情况很难与这些数据进行比较。本文讨论了哈萨克斯坦共和国2型糖尿病的患病率,以及年龄、种族、遗传易感性(OR = 3)、肥胖、血糖水平和总胆固醇等因素。结果发现,不同地区居民糖尿病的主要并发症和伴发疾病为:多神经病变22.4%、糖尿病视网膜病变14%、糖尿病足综合征13.6%、动脉高血压13.6%、冠心病14.4%。只有1.8%的人口被诊断为2型糖尿病,2型糖尿病的潜在表现,哈萨克斯坦四分之一的人可能患病,20-79岁的成年人中有38%患有前驱糖尿病,8.2%患有糖尿病。据信,到2030年,哈萨克斯坦可能会有大约100万糖尿病患者。根据哈萨克斯坦共和国《关于人民健康和卫生保健系统的法典》,糖尿病属于具有社会意义的疾病。因此,2型糖尿病的研究是哈萨克斯坦公共卫生领域亟待解决的问题之一。
{"title":"Issues of Type 2 Diabetes Disease Effective Treatment in Kazakhstan","authors":"N. Ablaikhanova","doi":"10.29169/1927-5951.2020.10.03.5","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.03.5","url":null,"abstract":"In his address to the people, the First President of our country, emphasized the need to introduce innovative methods of treating socially significant diseases. Among these diseases, diabetes holds a special position. More than 14,000 new cases of diabetes mellitus are officially detected annually in Kazakhstan. The real picture of the disease is difficult to compare with these data. This review discusses the prevalence of type 2 diabetes among the population of the Republic of Kazakhstan, and the causing factors such as age, race, genetic predisposition (OR = 3), obesity, glucose level and total cholesterol etc. It was found that the main complications and concomitant diseases of diabetes in residents of different regions are polyneuropathy 22.4%, diabetic retinopathy 14%, diabetic foot syndrome 13.6%, arterial hypertension 13.6% and coronary heart disease (CHD) 14.4%. Only 1.8% of the population is diagnosed with type 2 diabetes, latent manifestations of type 2 diabetes mellitus, one in four people in Kazakhstan can be sick, 38% of adults aged 20-79 suffer from prediabetes, and 8.2% with diabetes. It is believed that by 2030 in Kazakhstan, there may be about a million patients with diabetes. Diabetes mellitus, in accordance with the Code of the Republic of Kazakhstan “On the health of the people and the health care system” belongs to the category of socially significant diseases. Therefore, the study of type 2 diabetes is one of the urgent problems of the public health in Kazakhstan.","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"266 1","pages":"116-122"},"PeriodicalIF":0.0,"publicationDate":"2020-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86344980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prevalence of Iron Deficiency Anemia among Adolescent Girls in the City of Saravan - 萨拉万市少女缺铁性贫血的患病率
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-04-05 DOI: 10.29169/1927-5951.2020.10.02.4
Sabet Ghadam, M. Fararouei, M. Shahraki, Z. Sohrabi
Background and Objective: Iron deficiency anemia (IDA) is the most common type of micronutrient deficiency in the world. Numerous reports indicated that adolescence is a period which has an increased risk of development of IDA. Given the importance of IDA and lack of studies in Saravan, a city of Iran, this study was performed to assess the prevalence of IDA among adolescent girls.Methods: In this cross-sectional study, 460 high-school girls were randomly selected. Demographic data was collected using a questionnaire. Knowledge, attitude and practice of participants with regard to iron deficiency anemia was measured at the beginning of the interview. Accordingly, five cc of blood sample was drawn from each student to determine the prevalence of anemia, which was defined by a hemoglobin level lower than 12 mg / dL. The level of ferritin was analyzed to confirm the IDA for students diagnosed with anemia. Ferritin level lower than 12 ?g / dl was considered as IDA. Data was analyzed using SPSS software version 22.Results: Prevalence of anemia and IDA was 24% (n = 111) and 12.6% (n = 58), respectively. Results showed that 37 % of students had good knowledge, 45. 5 % good attitude, and 6.7 % had good practice. Also, there was no significant association between IDA and socio-economic status including parental education, job, and household income (P>0.05).Conclusion: The findings of this study showed that the prevalence of IDA was moderate in Saravan city. Given the importance of IDA and its complications, further studies are needed, especially in high risk populations for IDA such as children.
背景与目的:缺铁性贫血(IDA)是世界上最常见的微量营养素缺乏症。许多报告表明,青春期是IDA发展风险增加的时期。鉴于IDA的重要性和伊朗萨拉万市缺乏相关研究,本研究旨在评估青春期女孩中IDA的患病率。方法:采用横断面研究方法,随机抽取高中女生460名。人口统计数据是通过问卷调查收集的。在访谈开始时测量参与者对缺铁性贫血的知识、态度和行为。因此,从每个学生身上抽取5毫升血液样本来确定贫血的患病率,贫血的定义是血红蛋白水平低于12毫克/分升。分析铁蛋白水平以确定诊断为贫血的学生的IDA。铁蛋白水平低于12 ?g / dl为IDA。数据采用SPSS软件22进行分析。结果:贫血和IDA患病率分别为24% (n = 111)和12.6% (n = 58)。结果显示,有良好知识的学生占37%,占45%。5%的人态度良好,6.7%的人行为良好。此外,IDA与父母教育程度、工作和家庭收入等社会经济状况无显著相关(P>0.05)。结论:本研究结果表明,萨拉万市的IDA患病率处于中等水平。鉴于IDA及其并发症的重要性,需要进一步研究,特别是在儿童等IDA高危人群中。
{"title":"Prevalence of Iron Deficiency Anemia among Adolescent Girls in the City of Saravan -","authors":"Sabet Ghadam, M. Fararouei, M. Shahraki, Z. Sohrabi","doi":"10.29169/1927-5951.2020.10.02.4","DOIUrl":"https://doi.org/10.29169/1927-5951.2020.10.02.4","url":null,"abstract":"Background and Objective: Iron deficiency anemia (IDA) is the most common type of micronutrient deficiency in the world. Numerous reports indicated that adolescence is a period which has an increased risk of development of IDA. Given the importance of IDA and lack of studies in Saravan, a city of Iran, this study was performed to assess the prevalence of IDA among adolescent girls.Methods: In this cross-sectional study, 460 high-school girls were randomly selected. Demographic data was collected using a questionnaire. Knowledge, attitude and practice of participants with regard to iron deficiency anemia was measured at the beginning of the interview. Accordingly, five cc of blood sample was drawn from each student to determine the prevalence of anemia, which was defined by a hemoglobin level lower than 12 mg / dL. The level of ferritin was analyzed to confirm the IDA for students diagnosed with anemia. Ferritin level lower than 12 ?g / dl was considered as IDA. Data was analyzed using SPSS software version 22.Results: Prevalence of anemia and IDA was 24% (n = 111) and 12.6% (n = 58), respectively. Results showed that 37 % of students had good knowledge, 45. 5 % good attitude, and 6.7 % had good practice. Also, there was no significant association between IDA and socio-economic status including parental education, job, and household income (P>0.05).Conclusion: The findings of this study showed that the prevalence of IDA was moderate in Saravan city. Given the importance of IDA and its complications, further studies are needed, especially in high risk populations for IDA such as children.","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83130399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Pharmacy and Nutrition Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1